India to Canada: Carmustine Export Trade Route
India has recorded 10 verified shipments of Carmustine exported to Canada, representing a combined trade value of $2.8M USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $282.8K USD. The leading Indian exporter is MSN LABORATORIES PRIVATE LIMITED, which accounts for 79% of total export value with 8 shipments worth $2.2M USD. On the buying side, STERIMAX INC is the largest importer in Canada with $1.9M USD in purchases. The top 3 suppliers — MSN LABORATORIES PRIVATE LIMITED, EMCURE PHARMACEUTICALS LIMITED , MSN LABORATORIES PRIVATE LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Canada Carmustine corridor is one of India's established pharmaceutical export routes, with 10 shipments documented worth a combined $2.8M USD. The route is dominated by MSN LABORATORIES PRIVATE LIMITED, which alone accounts for roughly 79% of all export value, reflecting the consolidated nature of India's carmustine manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $282.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during July–September, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 20.3%, placing it at rank #6 among India's top carmustine export destinations globally.
On the import side, key buyers of Indian carmustine in Canada include STERIMAX INC, MARCAN PHARMACEUTICALS INC., , TO THE ORDER OF and 1 others. STERIMAX INC is the single largest importer with 7 shipments valued at $1.9M USD.
Route Characteristics
- Average transit18 days
- Peak seasonQ3
- Primary modeMulti-modal
- Top portHYDERABAD AIR
Market Position
- Global rank#6
- Annual growth+20.3%
- Demand growth+17.4%
- Regulatory ease70/100
Top 10 Indian Carmustine Exporters to Canada
Showing top 10 of 3 Indian suppliers exporting Carmustine to Canada, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MSN LABORATORIES PRIVATE LIMITED Avg $278.9K per shipment | 8 | $2.2M | 78.9% |
| 2 | EMCURE PHARMACEUTICALS LIMITED Avg $595.8K per shipment | 1 | $595.8K | 21.1% |
| 3 | MSN LABORATORIES PRIVATE LIMITED Avg $232 per shipment | 1 | $232 | 0.0% |
This table shows the top 10 of 3 Indian companies exporting carmustine to Canada, ranked by total trade value. The listed exporters are: MSN LABORATORIES PRIVATE LIMITED, EMCURE PHARMACEUTICALS LIMITED , MSN LABORATORIES PRIVATE LIMITED . MSN LABORATORIES PRIVATE LIMITED is the dominant supplier with 8 shipments worth $2.2M USD, giving it a 79% market share.
Top 10 Carmustine Importers in Canada
Showing top 10 of 4 known buyers in Canada receiving Carmustine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian carmustine in Canada include STERIMAX INC, MARCAN PHARMACEUTICALS INC., , TO THE ORDER OF, STERIMAX INC. . The largest importer is STERIMAX INC, accounting for $1.9M USD across 7 shipments — representing 66% of all carmustine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | STERIMAX INC | 7 | $1.9M | 66.3% |
| 2 | MARCAN PHARMACEUTICALS INC., | 1 | $595.8K | 21.1% |
| 3 | TO THE ORDER OF | 1 | $357.5K | 12.6% |
| 4 | STERIMAX INC. | 1 | $232 | 0.0% |
Top 10 Carmustine Formulations Imported by Canada
Showing top 10 of 9 product formulations shipped on the India to Canada Carmustine route, ranked by trade value
Canada imports a wide range of carmustine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — CARMUSTINE FOR INJECTION USP 100 MG (900PAC) — accounts for $990.9K USD across 2 shipments. A total of 9 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CARMUSTINE FOR INJECTION USP 100 MG (900PAC) | 2 | $990.9K | 35.0% |
| 2 | COMBI PACK BICNU(CARMUSTINE FOR INJ 100M | 1 | $595.8K | 21.1% |
| 3 | CARMUSTINE FOR INJECTION USP 100 MG (900PAC)900NOS550 | 1 | $495.0K | 17.5% |
| 4 | MSN PHARMA CARMUSTINE FOR INJECTION USP100 MG | 1 | $357.5K | 12.6% |
| 5 | CARMUSTINE FOR INJECTION USP 100 MG (350PAC) | 1 | $192.5K | 6.8% |
| 6 | CARMUSTINE FOR INJECTION USP 100 MG (350PAC)350NOS550 | 1 | $192.5K | 6.8% |
| 7 | CARMUSTINE DILUENT VIAL (61 PAC) | 1 | $1.5K | 0.1% |
| 8 | CARMUSTINE DILUENT VIAL (61 PAC)61NOS25 | 1 | $1.5K | 0.1% |
| 9 | CARMUSTINE FOR INJECTION 100MG/VIAL | 1 | $232 | 0.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 69% sea for bulk, 18% air for urgent orders.
Top Ports of Origin
HYDERABAD AIR handles the highest volume with 6 shipments. Transit time averages 18 days by sea.
Market Dynamics
India's carmustine exports to Canada are driven primarily by a handful of large-scale manufacturers. MSN LABORATORIES PRIVATE LIMITED with 8 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MSN LABORATORIES PRIVATE LIMITED, EMCURE PHARMACEUTICALS LIMITED , MSN LABORATORIES PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $282.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as combi pack bicnu(carmustine for inj 100m and carmustine for injection usp 100 mg (900pac)900nos550, suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, STERIMAX INC is the largest importer with 7 shipments worth $1.9M USD — representing 66% of all carmustine imports from India on this route.
Route Statistics
- Trade Volume
- $2.8M
- Avg. Shipment
- $282.8K
- Suppliers
- 3
- Buyers
- 4
- Transit (Sea)
- ~18 days
- Annual Growth
- +20.3%
Related Analysis
Other Carmustine Routes
Unlock the Full India to Canada Carmustine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 10 shipments on this route.
Frequently Asked Questions — India to Canada Carmustine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Carmustine to Canada?
The leading Indian exporters of Carmustine to Canada are MSN LABORATORIES PRIVATE LIMITED, EMCURE PHARMACEUTICALS LIMITED , MSN LABORATORIES PRIVATE LIMITED . MSN LABORATORIES PRIVATE LIMITED holds the largest market share at approximately 79% of total trade value on this route.
Q What is the total value of Carmustine exports from India to Canada?
India exports Carmustine to Canada worth approximately $2.8M USD across 10 recorded shipments. The average value per shipment is $282.8K USD.
Q Which ports does India use to ship Carmustine to Canada?
The most active port of origin is HYDERABAD AIR with 6 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 69% of shipments going by sea and 18% by air.
Q How long does shipping take from India to Canada for Carmustine?
The average transit time for Carmustine shipments from India to Canada is approximately 18 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Canada Carmustine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 20.3% with demand growth tracking at 17.4%. The route is ranked #6 among India's top Carmustine export destinations globally.
Q How many suppliers are active on the India to Canada Carmustine route?
There are currently 3 active Indian suppliers exporting Carmustine to Canada. The market is moderately concentrated with MSN LABORATORIES PRIVATE LIMITED accounting for 79% of total shipment value.
Q Who are the main importers of Carmustine from India in Canada?
The leading importers of Indian Carmustine in Canada include STERIMAX INC, MARCAN PHARMACEUTICALS INC., , TO THE ORDER OF, STERIMAX INC. . STERIMAX INC is the largest buyer with 7 shipments worth $1.9M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Canada export trade corridor identified from Indian Customs (DGFT) records for Carmustine.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 4 importers in Canada matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 10 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
10 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists